Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Australian small caps rose as mining and biotech firms advanced, with key deals in graphite, rare earths, and lithium.
The S&P/ASX 200 dipped on Wednesday, but small-cap stocks rose as mining and biotech firms advanced.
Volt Resources secured a $11.1 million investment from Unbounded Opportunities Fund to redevelop its Tanzanian graphite project with improved efficiency.
Lindian Resources completed its acquisition of Malawi’s Kangankunde rare earths project, gaining full control of a major deposit.
Orthocell launched its nerve repair device in Hong Kong, marking its first Asian commercial sale.
European Lithium formed a joint venture with a Romanian state company to develop lithium resources.
Other firms, including Astral Resources and International Graphite, also reported progress in gold, graphite, and lithium projects, reflecting ongoing momentum in critical minerals and biotech sectors.
Las pequeñas capitalizaciones australianas subieron a medida que las empresas mineras y de biotecnología avanzaron, con acuerdos clave en grafito, tierras raras y litio.